← European Medicine Shortage Tracker · all medicines
Lidocainhydrochlorid-Monohydrat currently has availability issues reported in 5 European registers: Austria, Germany, Greece, Italy, Sweden.
Shortage ATC N01BB02 · also listed as: LIDOCAIN HYDROCHLORID MONOHYDRAT · Lidocainhydrochlorid-Monohydrat · LIDOCAINA · lidokainhydrokloridmonohydrat · data refreshed 7 August 2026
As of 7 August 2026, 5 of the 10 tracked registers list current availability issues for Lidocainhydrochlorid-Monohydrat, covering 8 affected product presentations. The longest-running open report was filed in Italy on 2025-06-15 and has now been open for about 14 months. Where agencies state a cause, manufacturing problems lead with 1 of the 2 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2027-10-01; the earliest is 2026-09-30. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2025-06-15), with Germany following roughly 13 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Lidocainhydrochlorid-Monohydrat is coded N01BB02 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Xylocain 2 % - Gel | 2026-04-24 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Xylocain Gel 2% | 2026-07-28 | 2026-10-09 | Probleme in der Herstellung Alternatives: Xylocain Gel 2% - Einreichungsnummer: 0077215 | register ↗ |
| 🇬🇷 Greece | Limited availability XYLOCAINE GEL.EXT.US 2% W/W TUBx30G | 2026-04-17 | 2026-07-31 | διαδικασία Εναλλακτικά το ίδιο φάρμακο σε διαφορετική μορφή | register ↗ |
| 🇮🇹 Italy | Shortage TRUVINUT | 2025-06-15 | — | Sospensione commercializzazione Alternatives: AIFA: an alternative treatment is available (ask your doctor). | register ↗ |
| 🇸🇪 Sweden | Shortage Lidocaine Accord 10 mg/ml Injektionsvätska, lösning + 3 more productsLidokain Aguettant 10 mg/ml Injektionsvätska, lösning i förfylld spruta Lidokain Aguettant 20 mg/ml Injektionsvätska, lösning i förfylld spruta Xylocain 20 mg/g Gel | 2025-10-01 | 2027-10-01 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Lidocainhydrochlorid-Monohydrat in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Xylocain Gel 2% | Shortage | 2026-07-28 | 2026-10-09 | Probleme in der Herstellung |
| 🇸🇪 SE | Lidocaine Accord 10 mg/ml Injektionsvätska, lösning | Shortage | 2026-05-18 | 2026-12-31 | |
| 🇸🇪 SE | Xylocain 20 mg/g Gel | Shortage | 2026-04-27 | 2026-09-30 | |
| 🇦🇹 AT | Xylocain 2 % - Gel | Shortage | 2026-04-24 | — | |
| 🇬🇷 GR | XYLOCAINE GEL.EXT.US 2% W/W TUBx30G | Limited availability | 2026-04-17 | 2026-07-31 | διαδικασία Εναλλακτικά το ίδιο φάρμακο σε διαφορετική μορφή |
| 🇸🇪 SE | Lidokain Aguettant 10 mg/ml Injektionsvätska, lösning i förfylld sprut | Shortage | 2025-10-01 | 2027-10-01 | |
| 🇸🇪 SE | Lidokain Aguettant 20 mg/ml Injektionsvätska, lösning i förfylld sprut | Shortage | 2025-10-01 | 2027-10-01 | |
| 🇮🇹 IT | TRUVINUT | Shortage | 2025-06-15 | — | Sospensione commercializzazione |
Yes. As of 7 August 2026, availability issues are reported in: Austria, Germany, Greece, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2027-10-01. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
6 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Lidocainhydrochlorid-Monohydrat: BASG (Austria), BfArM (Germany), EOF limited-availability list (Greece), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Lidocainhydrochlorid-Monohydrat — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lidocainhydrochlorid-monohydrat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Lidocainhydrochlorid-Monohydrat availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lidocainhydrochlorid-monohydrat/">Lidocainhydrochlorid-Monohydrat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>